Pfam Domains GO Terms
| Ank 2 |
| cyclin D2-CDK4 complex |
| autophagic cell death |
| cyclin-dependent protein serine/threonine kinase inhibitor activity |
| negative regulation of cyclin-dependent protein serine/threonine kinase activity |
| response to vitamin D |
| negative regulation of cyclin-dependent protein kinase activity |
| negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| DNA synthesis involved in DNA repair |
| negative regulation of response to DNA damage stimulus |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| response to vitamin |
| negative regulation of cysteine-type endopeptidase activity |
| negative regulation of intrinsic apoptotic signaling pathway |
| regulation of cyclin-dependent protein serine/threonine kinase activity |
| regulation of cyclin-dependent protein kinase activity |
| negative regulation of G1/S transition of mitotic cell cycle |
| negative regulation of cell cycle G1/S phase transition |
| response to retinoic acid |
| DNA biosynthetic process |
| G1/S transition of mitotic cell cycle |
| cell cycle G1/S phase transition |
| negative regulation of protein serine/threonine kinase activity |
| response to UV |
| cell cycle arrest |
| sensory perception of sound |
| regulation of G1/S transition of mitotic cell cycle |
| regulation of intrinsic apoptotic signaling pathway |
| regulation of cell cycle G1/S phase transition |
| sensory perception of mechanical stimulus |
| negative regulation of cell growth |
| negative regulation of mitotic cell cycle phase transition |
| response to nutrient |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of response to DNA damage stimulus |
| negative regulation of apoptotic signaling pathway |
| negative regulation of protein kinase activity |
| negative regulation of cell cycle phase transition |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of growth |
| negative regulation of endopeptidase activity |
| negative regulation of kinase activity |
| negative regulation of peptidase activity |
| mitotic cell cycle phase transition |
| negative regulation of transferase activity |
| cell cycle phase transition |
| negative regulation of mitotic cell cycle |
| response to light stimulus |
| negative regulation of cell cycle process |
| response to acid chemical |
| negative regulation of proteolysis |
| regulation of apoptotic signaling pathway |
| negative regulation of protein phosphorylation |
| regulation of mitotic cell cycle phase transition |
| regulation of endopeptidase activity |
| regulation of cell growth |
| response to radiation |
| negative regulation of phosphorylation |
| regulation of peptidase activity |
| regulation of cell cycle phase transition |
| negative regulation of hydrolase activity |
| protein kinase binding |
| response to nutrient levels |
| negative regulation of intracellular signal transduction |
| DNA repair |
| regulation of protein serine/threonine kinase activity |
| response to extracellular stimulus |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| negative regulation of cell cycle |
| negative regulation of protein modification process |
| mitotic cell cycle process |
| regulation of mitotic cell cycle |
| regulation of growth |
| negative regulation of cell population proliferation |
| mitotic cell cycle |
| regulation of proteolysis |
| regulation of cellular response to stress |
| DNA metabolic process |
| regulation of cell cycle process |
| cellular response to DNA damage stimulus |
| negative regulation of catalytic activity |
| regulation of protein kinase activity |
| response to lipid |
| regulation of kinase activity |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| response to organic cyclic compound |
| sensory perception |
| regulation of transferase activity |
| negative regulation of cell death |
| cell cycle process |
| negative regulation of cellular protein metabolic process |
| programmed cell death |
| cell death |
| nucleobase-containing compound biosynthetic process |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| response to abiotic stimulus |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| regulation of cell cycle |
| negative regulation of signal transduction |
| regulation of hydrolase activity |
| organic cyclic compound biosynthetic process |
| cell cycle |
| negative regulation of cell communication |
| negative regulation of signaling |
| nervous system process |
| regulation of protein phosphorylation |
| regulation of response to stress |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| regulation of phosphorylation |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| cellular nitrogen compound biosynthetic process |
| regulation of cell death |
| cellular response to stress |
| cellular macromolecule biosynthetic process |
| macromolecule biosynthetic process |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
| system process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution